Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery

References

• He L, Tong X, Zeng J, et al. Paeonol suppresses neuroinflammatory responses in lps-activated microglia cells. Inflammation. 2016;39(6):1904–1917. doi:10.1007/s10753-016-0426-z27624059
   PubMed Web of Science ®Google Scholar
• Shi X, Chen Y, Liu H, et al. Therapeutic effects of paeonol on methyl-4-phenyl −1, 2, 3, 6-tetrahydropyridine/probenecid-induced Parkinson’s disease in mice. Mol Med Rep. 2016;14:2397–2404.27484986
   PubMed Web of Science ®Google Scholar
• Zhao Y, Fu B, Zhang X, et al. Paeonol pretreatment attenuates cerebral ischemic injury via upregulating expression of pAkt, Nrf2, HO-1 and ameliorating BBB permeability in mice. Brain Res Bull. 2014;109:61–67.25286445
   PubMed Web of Science ®Google Scholar
• Gyawal A, Krol S, kang YS. Involvement of a novel organic cation transporter in paeonol transport across the blood-brain barrier. Biomol Ther. 2019;27:290–301.
   PubMed Web of Science ®Google Scholar
• Zsikó S, Cutcher K, Kovács A, et al. Nanostructured lipid carrier gel for the dermal application of lidocaine: comparison of skin penetration testing methods. Pharmaceutics. 2019;11:310.
   PubMed Web of Science ®Google Scholar
• Tapeinos C, Battaglini M, Ciofani G. Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. J Controlled Release. 2017;264:306–332.
   PubMed Web of Science ®Google Scholar
• Tzeyung AS, Shadab M, Bhattamisra SK, et al. Fabrication, optimization, and evaluation of rotigotine-loaded chitosan nanoparticles for nose-to-brain delivery. Pharmaceutics. 2019;11:26.
   PubMed Web of Science ®Google Scholar
• Espinoza LC, Abreu MS, Clares B, et al. Formulation strategies to improve nose-to-brain delivery of donepezil. Pharmaceutics. 2019;11:64.
   PubMed Web of Science ®Google Scholar
• Bonferoni MC, Rossi S, Sandri G, et al. Nanoemulsions for “nose-to-brain” drug delivery. Pharmaceutics. 2019;11:84.
   PubMed Web of Science ®Google Scholar
• Bonferoni MC, Ferraro L, Pavan B, et al. Uptake in the central nervous system of geraniol oil encapsulated in chitosan oleate following nasal and oral administration. Pharmaceutics. 2019;11(3):106. doi:10.3390/pharmaceutics11030106
   PubMed Web of Science ®Google Scholar
• Chu K, Chen L, Xu W, et al. Preparation of a paeonol-containing temperature-sensitive in situ gel and its preliminary efficacy on allergic rhinitis. Int J Mol Sci. 2013;14:6499–6515.23525047
   PubMed Web of Science ®Google Scholar
• Youssef N, Kassem AA, Farid RM, et al. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: preparation, characterization and in vivo evaluation. Int J Pharm. 2018;548:609–624.30033394
   PubMedGoogle Scholar
• Mura P, Mennini N, Nativi C, et al. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin. Eur J Pharm Biopharm. 2018;122:54–61.29032194
   PubMed Web of Science ®Google Scholar
• Ahmed TA, Khalid ME-S, Osama AAA, et al. Superiority of TPGS -loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel. Int J Nanomed. 2019;14:5555–5567.
   PubMed Web of Science ®Google Scholar
• Dewan M, Sarkar G, Bhowmik M, et al. Effect of gellan gum on the thermogelation property and drug release profile of poloxamer 407 based ophthalmic formulation. Int J Biol Macromol. 2017;102:258–265.28390828
   PubMed Web of Science ®Google Scholar
• Zaki NM, Awad GA, Mortada ND, et al. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sc. 2007;32:296–307.17920822
   PubMed Web of Science ®Google Scholar
• Hao JF, Zhao J, Zhang S, et al. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery. Colloids Surf B. 2016;147:376–386.
   PubMed Web of Science ®Google Scholar
• Salunke SR, Patil SB. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration. Int J Biol Macromol. 2016;87:41–47.26899173
   PubMed Web of Science ®Google Scholar
• Fatouh AM, Elshafeey AH, Abdelbary A. Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation. Drug Deliv. 2017;24:1077–1085.28745530
   PubMed Web of Science ®Google Scholar
• Mahajan HS, Tyagi V, Lohiya G, et al. Thermally reversible xyloglucan gels as vehicles for nasal drug delivery. Drug Deliv. 2012;19:270–275.22823894
   PubMed Web of Science ®Google Scholar
• Hosny KM, Hassan AH. Intranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluation. Int J Pharm. 2014;475:191–197.25178831
   PubMed Web of Science ®Google Scholar
• Shah V, Sharma M, Pandya R, et al. Quality by design approach for an in situ gelling microemulsion of lorazepam via intranasal route.mater. Sci Eng Carbon. 2017;75:1231–1241.
   PubMed Web of Science ®Google Scholar
• Mahajan HS, Gattani S. In situ gels of metoclopramide hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits. Drug Deliv. 2010;17:19–27.19958151
   PubMed Web of Science ®Google Scholar
• Gao Y, Liu R, Gautam N, et al. Determination of the in vitro metabolic stability and metabolites of the anticancer derivative riccardin D-N in human and mouse hepatic S9 fractions using HPLC-Q-LIT-MS. J Pharm Biomed Anal. 2019;174:734–743.31299454
   PubMed Web of Science ®Google Scholar
• Baea M, Leea Y, Parka YK, et al. Astaxanthin attenuates the increase in mitochondrial respiration during the activation of hepatic stellate cells. J Nutr Biochem. 2019;71:82–89.31302374
   PubMed Web of Science ®Google Scholar
• Kwon MH, Jeong JS, Ryu J, et al. Pharmacokinetics and brain distribution of the active components of da-9805, saikosaponin a, paeonol, and imperatorin in rats. Pharmaceutics. 2018;10:133.
   PubMed Web of Science ®Google Scholar
• Cho PJ, Paudel S, Lee D, et al. Characterization of CYPs and UGTs involved in human liver microsomal metabolism of osthenol. Pharmaceutics. 2018;10:141.
   PubMed Web of Science ®Google Scholar
• Khames A, Khalee MA, Mohamed FE-B, et al. Natamycin solid lipid nanoparticles – sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization. Int J Nanomed. 2019;14:2515–2531.
   PubMed Web of Science ®Google Scholar
• Kang J-H, Chon J, Kim Y-I, et al. Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution. Int J Nanomed. 2019;14:5381–5396.
   PubMed Web of Science ®Google Scholar
• Evan M CEM, Quijano AR, Seo YE, et al. Biodegradable PEG-poly (u-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors. Biomaterials. 2018;178:193–203.29936153
   PubMed Web of Science ®Google Scholar
• Stella B, Peira E, Dianzani C, et al. Development and characterization of solid lipid nanoparticles loaded with a highly active doxorubicin derivative. Nanomaterials. 2018;8:110.
   Web of Science ®Google Scholar
• Chirio D, Peira E, Dianzani C, et al. Development of solid lipid nanoparticles by cold dilution of microemulsions: curcumin loading, preliminary in vitro studies, and biodistribution. Nanomaterials. 2019;9:230.
   Web of Science ®Google Scholar
• Cao SL, Zhang QZ, Jiang XG. Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacy. Acta Pharmacol Sin. 2007;28:584–590.17376300
   PubMed Web of Science ®Google Scholar
• Gabal YM, Kamel AO, Sammour OA, et al. Sammour an effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route. Int J Pharm. 2014;473:442–457.25062866
   PubMed Web of Science ®Google Scholar
• Gänger S, Schindowski K. Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physicochemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics. 2018;10:116.
   PubMed Web of Science ®Google Scholar
• Ozbılgın ND, Saka OM, Bozkır A. Preparation and in vitro/in vivo evaluation of mucosal adjuvant in situ forming gels with diphtheria toxoid. Drug Deliv. 2014;21:140–147.24559517
   PubMed Web of Science ®Google Scholar
• Qian S, Wong YC, Zuo Z. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine. Int J Pharm. 2014;468:272–282.24709220
   PubMed Web of Science ®Google Scholar
• Ghadiri M, Young PM, Traini D. Strategies to enhance drug absorption via nasal and pulmonary routes. Pharmaceutics. 2019;11:113.
   PubMed Web of Science ®Google Scholar
• Chen Y-S, Chiu Y-H, Yuan-Sheng L, et al. Integration of PEG 400 into a self-nano emulsifying drug delivery system improves drug loading capacity and nasal mucosa permeability and prolongs the survival of rats with malignant brain tumors. Int J Nanomed. 2019;14:3601–3613.
   PubMed Web of Science ®Google Scholar
• Cao SL, Ren XW, Zhang QZ, et al. In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate. Int J Pharm. 2009;365:109–115.18822361
   PubMed Web of Science ®Google Scholar
• Musumeci T, Bonaccorso A, Puglisi G. Epilepsy disease and nose-to-brain delivery of polymeric nanoparticles: an overview. Pharmaceutics. 2019;11:118.
   PubMed Web of Science ®Google Scholar
• Sonvico F, Clementino A, Buttini F, et al. Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting. Pharmaceutics. 2018;10:34.
   PubMed Web of Science ®Google Scholar
• Ahmed S, Gull A, Aqil M, et al. Poloxamer-407 thickened lipid colloidal system of agomelatine for brain targeting: characterization, brain pharmacokinetic study and behavioral study on wistar rats. Colloids Surf B. 2019;181:426–436.
   PubMed Web of Science ®Google Scholar
• Zaafarany GME, Soliman ME, Mansour S, et al. A tailored thermosensitive PLGA-PEG-PLGA/emulsomes composite for enhanced oxcarbazepine brain delivery via the nasal route. Pharmaceutics. 2018;10:217.
   PubMed Web of Science ®Google Scholar
• Salem HF, Kharshoum RM, Abou-Taleb HA, et al. Nanosized transferosome-based intranasal in situ gel for brain targeting of resveratrol: formulation, optimization, in vitro evaluation, and in vivo pharmacokinetic study. AAPS PharmSciTech. 2019;20:181.31049748
   PubMed Web of Science ®Google Scholar
• NižićL, Ugrina I, Špoljarić D, et al. Innovative sprayable in situ gelling fluticasone suspension: development and optimization of nasal deposition. Int J Pharm. 2019;04:015.
   Google Scholar
• Zhou H, Ichikawa A, Takahashi YI, et al. Nanogels of succinylated glycol chitosan -succinyl prednisolone conjugate: preparation, in vitro characteristics and therapeutic potential. Pharmaceutics. 2019;11:333.
   PubMed Web of Science ®Google Scholar
• Gholizadeh H, Cheng S, Pozzoli M, et al. Smart thermosensitive chitosan hydrogel for nasal delivery of ibuprofen to treat neurological disorders. Exp Opin Drug Del. 2019;1742:5247.
   Google Scholar
• Xie H, Li L, Sun Y, et al. An available strategy for nasal brain transport of nanocomposite based on pamam dendrimers via in situ gel. Nanomaterials. 2019;9:147.
   Web of Science ®Google Scholar
• Tatke A, Dudhipala N, Janga KY, et al. In situ gel of triamcinolone acetonide-loaded solid lipid nanoparticles for improved topical ocular delivery: tear kinetics and ocular disposition studies. Nanomaterials. 2019;9:33.
   Web of Science ®Google Scholar
• Silva AM, Alvarado HL, Abrego G, et al. In vitro cytotoxicity of oleanolic/ursolic acids-loaded in plga nanoparticles in different cell lines. Pharmaceutics. 2019;11:362.
   PubMed Web of Science ®Google Scholar
• Sandri G, Motta S, Bonferoni MC, et al. Chitosan-coupled solid lipid nanoparticles: tuning nanostructure and mucoadhesion. Eur J Pharm Biopharm. 2016;110:13–18.27989765
   PubMed Web of Science ®Google Scholar
• Jannina V, Blasb L, Chevriera S, et al. Evaluation of the digestibility of solid lipid nanoparticles of glyceryl dibehenate produced by two techniques: ultrasonication and spray-flash evaporation. Eur J Pharm Biopharm. 2018;111:91–95.
   Google Scholar
• Kim CH, Sung SW, Lee ES, et al. Sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: characterization, cellular uptake, cytotoxicity, and biodistribution. Pharmaceutics. 2018;10:199.
   PubMed Web of Science ®Google Scholar
• Montenegro L, Panico AM, Santagati LM, et al. Solid lipid nanoparticles loading idebenone ester with pyroglutamic acid: in vitro antioxidant activity and in vivo topical efficacy. Nanomaterials. 2019;9:43.
   Web of Science ®Google Scholar
• Arana L, Cordero LB, Sarasola LI, et al. Solid lipid nanoparticles surface modification modulates cell internalization and improves chemotoxic treatment in an oral carcinoma cell line. Nanomaterials. 2019;9:464.
   Web of Science ®Google Scholar
• Mishra V, Bansal KK, Verma A, et al. Solid lipid nanoparticles: emerging colloidal nano drug delivery systems. Pharmaceutics. 2018;10:191.
   PubMed Web of Science ®Google Scholar
• Baek JS, Na YG, Cho CW. Sustained cytotoxicity of wogonin on breast cancer cells by encapsulation in solid lipid nanoparticles. Nanomaterials. 2018;8:159.
   Web of Science ®Google Scholar
• Wu X, Chen H, Wu C, et al. Inhibition of intrinsic coagulation improves safety and tumor-targeted drug delivery of cationic solid lipid nanoparticles. Biomaterials. 2018;156:77–87.29190500
   PubMed Web of Science ®Google Scholar
• Shen MY, Liu TI, Yu TW, et al. Hierarchically targetable polysaccharide-coated solid lipid nanoparticles as an oral chemo/thermotherapy delivery system for local treatment of colon cancer. Biomaterials. 2019;197:86–100.30641267
   PubMed Web of Science ®Google Scholar
• Meng Q, Wang A, Hua H, et al. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease. Int J Nanomed. 2018;13:705–718.
   PubMed Web of Science ®Google Scholar
• Yan X, Lixiao X, Chenchen B, et al. Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MSbased drug biodistribution, pharmacodynamics, and neuroprotective effects. Int J Nanomed. 2018;13:273–281.
   PubMed Web of Science ®Google Scholar
• Perez AP, Mundiña-Weilenmann C, Romero EL, et al. Increased brain radioactivity by intranasal 32P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels. Int J Nanomed. 2012;7:1373–1385.
   PubMed Web of Science ®Google Scholar